iMATEs – A successful immunotherapy against chronic viral infection
Chronic liver infections are difficult to overcome due to mechanisms that limit the function and population expansion of cytotoxic effector CD8+ T cells (cytotoxic T lymphocytes (CTLs)). This limitation may protect the infected liver from overwhelming immunopathology by inducing oscillatory CTL effector function but may also functionally compromise pathogen-specific CTLs. However, large numbers of parasite-specific CTLs are needed to eradicate infected hepatocytes.
A new therapeutic vaccination strategy could solve the problem by using Toll-like receptor ligands as an unspecific enhancer: The induction of intrahepatic myeloid cell aggregates through application of Toll-like receptor 9 agonist (TLR9 ligand) enables massive expansion of the CTL population locally in the liver. The intrahepatic myeloid-cell aggregates for T cell population expansion (iMATEs) are rapidly formed within 2d after TLR9 signaling and provide a nonperfused cocoon-like anatomic structure for local CTL proliferation. Thus, such population expansion of CTLs in the liver controls acute and chronic viral infection of the liver and can eradicate chronic viral infection
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 10
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Magnetic tornado is stirring up the haze at Jupiter’s poles
Unusual magnetically driven vortices may be generating Earth-size concentrations of hydrocarbon haze. While Jupiter’s Great Red Spot has been a constant feature of the planet for centuries, University of California,…
Cause of common cancer immunotherapy side effect s
New insights into how checkpoint inhibitors affect the immune system could improve cancer treatment. A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation…
New tool makes quick health, environmental monitoring possible
University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, environmental monitoring groups, or even you, the ability to quickly detect harmful and health-relevant substances…